EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Conserved Pathways, Divergent Outcomes: A Cross-Species Genomic Perspective on the Cancer–Neurodegeneration Paradox

Bhargavi Rajarathinam, Durga Nandan iD, Parvathy Venugopal, Amritha M Nair, Subin John, Bipin G Nair, Rajaguru Aradhya

International Journal of Molecular Sciences · 25.03.2026 · 27 (7) · 2989

DOI: 10.3390/ijms27072989 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.03.2026. Verfasst von Bhargavi Rajarathinam und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Biotechnology, Amrita Vishwa Vidyapeetham, Kollam 690525, Kerala, India. Hauptthemen laut MEDLINE: Neoplasms, Genomics, Signal Transduction, Neurodegenerative Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 369 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegeneration and cancer are fundamentally distinct disorders: one signifies gradual neuronal loss while the latter signifies uncontrolled cell growth and survival. However, emerging evidence explores an inverse association between these conditions, suggesting that they do not arise from independent biological processes. Understanding the context-dependent behaviour of major pathways (for example, p53, PI3K/AKT/mTOR, Wnt, and immune–stress signaling) remains pivotal in elucidating the relationship between these two diseases. Pathways promoting early-life fitness, tissue repair, and tumor suppression in dividing cells can become detrimental later in life for post-mitotic neurons. Cross-species genomics studies reveal how evolution has repeatedly adapted these shared networks to balance cancer resistance with survival. Research on species exhibiting exceptional longevity and disease resistance, including naked mole rats and bowhead whales, shows that cancer resistance and longevity are not fixed traits but rather are controlled by precise regulatory mechanisms. In this review, we integrate insights from broad species genomics and multi-omic and single-cell studies to understand how evolutionarily conserved molecular crosstalks diverge at the interface of cancer and neurodegeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsGenomicsSignal TransductionNeurodegenerative DiseasesAnimalsHumansEvolution, MolecularLongevitySpecies Specificity

Stichwörter der Autor:innen

Peto’s paradoxantagonistic pleiotropycomparative oncologycross-species genomicsevolutionary paradoxneuroprotectiontumor suppressor genes

Autor:innen und Institutionen

  • School of Biotechnology, Amrita Vishwa Vidyapeetham, Kollam 690525, Kerala, India.

ORCID-Profile: Durga Nandan

Zitieren

APA

Rajarathinam, B., Nandan, D., Venugopal, P., Nair, A. M., John, S., Nair, B. G., & Aradhya, R. (2026). Conserved Pathways, Divergent Outcomes: A Cross-Species Genomic Perspective on the Cancer–Neurodegeneration Paradox. International Journal of Molecular Sciences, 27(7), 2989. https://doi.org/10.3390/ijms27072989

Vancouver

Rajarathinam B, Nandan D, Venugopal P, Nair AM, John S, Nair BG, et al. Conserved Pathways, Divergent Outcomes: A Cross-Species Genomic Perspective on the Cancer–Neurodegeneration Paradox. International Journal of Molecular Sciences. 2026;27(7):2989. doi:10.3390/ijms27072989

BibTeX
@article{Rajarathinam2026,
  author = {Rajarathinam, Bhargavi and Nandan, Durga and Venugopal, Parvathy and Nair, Amritha M and John, Subin and Nair, Bipin G and Aradhya, Rajaguru},
  title = {Conserved Pathways, Divergent Outcomes: A Cross-Species Genomic Perspective on the Cancer–Neurodegeneration Paradox},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {7},
  pages = {2989},
  doi = {10.3390/ijms27072989}
}
Kostenlos starten →